Maven Securities’s Surgery Partners SGRY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-25,000
Closed -$529K 964
2024
Q4
$529K Buy
+25,000
New +$656K 0.01% 570
2024
Q1
Sell
-331,955
Closed -$10.6M 883
2023
Q4
$10.6M Buy
+331,955
New +$9.63M 0.22% 77
2023
Q1
Sell
-150,000
Closed -$4.18M 1048
2022
Q4
$4.18M Buy
+150,000
New +$3.97M 0.09% 122
2021
Q3
Sell
-100,000
Closed -$6.57M 1248
2021
Q2
$6.57M Hold
100,000
0.26% 65
2021
Q1
$4.41M Buy
+100,000
New +$3.71M 0.2% 101

Other funds holding SGRY

Maven Securities's SGRY Position: Q1 2025 in Review

Maven Securities sold out of Surgery Partners (SGRY) in Q1 2025, closing a stake of 25,000 shares — an estimated $529K sold.

Maven Securities first reported a position in SGRY in Q1 2021 and held it in 5 quarters. The position peaked at $10.6M in Q4 2023. 208 funds tracked by Wall St. Rank hold SGRY as of Q1 2025.

  • Maven Securities reported no remaining Surgery Partners position as of Q1 2025 after selling out during the quarter.
  • Maven Securities sold 25,000 Surgery Partners shares in Q1 2025, an estimated $529K.
  • Maven Securities first reported a position in Surgery Partners in Q1 2021 and held it in 5 quarters.
  • Maven Securities's Surgery Partners position peaked at $10.6M in Q4 2023.
  • 208 funds tracked by Wall St. Rank held Surgery Partners as of Q1 2025.

Based on Maven Securities's 13F filing for Q1 2025, filed 14 May 2025.